BPC-157 · FAQ

    BPC-157: Frequently Asked Questions

    Common questions about BPC-157, answered from clinical reference documentation.

    Comparison

    BPC-157 vs TB-500

    FeatureBPC-157TB-500
    OriginGastric juice-derived pentadecapeptideThymosin Beta-4 synthetic fragment
    Primary actionCytoprotection, tendon/gut healingCell migration, angiogenesis
    AdministrationSubcutaneous or oralSubcutaneous or intramuscular
    FDA statusNot FDA-approvedNot FDA-approved
    Evidence levelExtensive preclinicalPreclinical

    Factual comparison only. No dosing information. Consult a qualified physician.

    Looking for a physician who prescribes BPC-157?

    Find a Provider

    Or see how peptide therapy near you works and request a referral.

    Browse all peptide FAQs